Ignoring SARS-CoV-2 testing performance during COVID-19.

Buchta, Christoph; Zeichhardt, Heinz; Griesmacher, Andrea; Schellenberg, Ingo; Kammel, Martin

Buchta, Christoph; Zeichhardt, Heinz; Griesmacher, Andrea; Schellenberg, Ingo; Kammel, Martin.

Buchta C; Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests, Vienna 1090, Austria. Electronic address: christoph.buchta@oequasta.at.
Zeichhardt H; INSTAND Society for Promoting Quality Assurance in Medical Laboratories, Düsseldorf, Germany; Institut für Qualitätssicherung in der Virusdiagnostik, Berlin, Germany; Gesellschaft für Biotechnologische Diagnostik, Berlin, Germany.
Griesmacher A; Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests, Vienna 1090, Austria.
Schellenberg I; INSTAND Society for Promoting Quality Assurance in Medical Laboratories, Düsseldorf, Germany.
Kammel M; INSTAND Society for Promoting Quality Assurance in Medical Laboratories, Düsseldorf, Germany; Gesellschaft für Biotechnologische Diagnostik, Berlin, Germany.

Lancet Microbe ; 4(5): e296, 2023 05.

Article in English | MEDLINE | ID: covidwho-2221546

Subject(s)

COVID-19; Humans; SARS-CoV-2; COVID-19 Testing; Sensitivity and Specificity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Lancet Microbe Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google